Navigation Links
Clinical studies in the pipeline: the therapies of tomorrow in trials today
Date:10/23/2007

rm study so there is need for more research to confirm this potential benefit, and to examine safety more closely. The treatment was generally well tolerated in most patients, Dr. Zhu says, but adds that grade three and four toxicities were observed in approximately three to 20 percent of patients, depending on the specific side effect.

HCC is most commonly found in patients with chronic viral hepatitis (B or C) or with cirrhosis, and surgery to remove tumors is only possible in a small percentage of patients. Generally, patients have a poor prognosis because these tumors produce a lot of proteins, such as VEGF and VEGFR2, that make them highly vascular and able to build a solid and nurturing blood supply with increased ability to invade surrounding major vessels and to metastasize, Dr. Zhu says. Sunitinib is a receptor tyrosine kinase inhibitor designed to target and block VEGFR2 activity, among other pro-growth molecules.

To find out if sunitinib could target HCC, the research team employed a number of research tools to measure changes in the patients blood and tumor perfusion. Instead of just trying to determine if the drug is attacking the tumor, we want to get a sense of what kind of changes the agent might be inducing, Dr. Zhu said. We want to know what the mechanisms are that might confer benefit as well as toxicity.

The team used dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to assess changes in the permeability of tumor blood vessels and found that it decreased by an average of 38 percent after two weeks of sunitinib therapy. Using protein arrays to test for angiogenic biomarkers in the blood, the investigators found that the levels of VEGF and PIGF increased, while that of soluble VEGFR2 declined in most patients. Also, flow cytometry analyses of blood cells suggested that circulating endothelial cells increased in some patients while circulating progenitor cells were significantly decreased, indicating that sun
'/>"/>

Contact: Greg Lester
greg.lester@aacr.org
267-646-0554
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related medicine news :

1. How do patients benefit of clinical trials
2. Magnetic resonance angiography in clinical medicine
3. Clinical trials need to be more frank
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
6. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
7. Clinical Comparisons Between ADHD Drugs Are Less
8. Outsourcing clinical trials to India
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. A Novel System For Clinical Banking Of Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... York (PRWEB) , ... July 02, 2015 , ... It’s no secret that what we consume can have an effect ... many people can easily feel dehydrated or perhaps even undernourished if not eating enough of the ... it can be an easy time of year to overdo it on the food front as ...
(Date:7/2/2015)... ... July 02, 2015 , ... Denver-based SlimGenics Weight Control ... was named No. 14 on ColoradoBiz magazine’s Top 100 Woman-Owned Companies list. ColoradoBiz ... been recognized. The award identifies outstanding woman-owned businesses that demonstrate excellence and success ...
(Date:7/1/2015)... ... July 01, 2015 , ... Dr. Jian-Dong Li, a professor ... a Georgia Research Alliance Eminent Scholar in Inflammation and Immunity, has received a ... , The grant from the National Institute on Deafness and Other Communication Disorders ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... they will welcome four new members to their industry leading Scientific Advisory Board. ...
(Date:7/1/2015)... ... , ... Dr. Surya Challa of Chesapeake Vein Center and MedSpa in Chesapeake, ... to discuss non-invasive CoolSculpting . On the show, Dr. Challa will explain how ... reduction utilizes Cryolipolysis to literally freeze stubborn, unwanted fat away and give patients the ...
Breaking Medicine News(10 mins):Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3
... Register for ... ... -- In June of 2009, the world reached a turning point in our history. The ... result of the recent contested presidential election, demonstrations and protests ensued. The government,s crack-down on ...
... National poll finds kids in poorest families feel effects most ... taking a toll on many U.S. children, especially the poor ... their children. , The poll, conducted in the United States ... worsened in the previous six months, forcing them to spend ...
... in nonsmoking patients; could be target for treatment , ... a small molecule that might play a big part ... people who have never smoked, opening up the possibilities ... microRNA miR-21 was found particularly elevated in adenocarcinomas that ...
... ... iCRco completed its annual Asia/Pacific distributor training program in Suzhou, China, with over 60 ... ... training program in Suzhou, China, with over 60 representatives in attendance., , ,This year,s ...
... , , TIJUANA, Mexico, July 17 ... Throughout Mexico, childcare center owners are being crucified unjustly. Following a ... in Hermosillo, Sonora, the entire country has risen up in arms ... Eli Grey, whose family owns multiple centers and runs Interchildren, believes ...
... July 17 The economic downturn is impacting the health of many people ... by causing people to put off getting the health care they need. , ... offering suggestions for how to get them most for your money when it ... t put off necessary treatment , Fears about possible ...
Cached Medicine News:Health News:reThinking eHealth Webinar Announced: Hospital Marketing in the eHealth Era 2Health News:Recession Takes Toll on Children's Health 2Health News:Small Molecule Might Play Big Part in Lung Cancer 2Health News:Small Molecule Might Play Big Part in Lung Cancer 3Health News:iCRco Conducts 2009 Asia/Pacific Distributor Training Program 2Health News:iCRco Conducts 2009 Asia/Pacific Distributor Training Program 3Health News:Child Care Centers Throughout Mexico Being Crucified Unjustly, Says Interchildren, Inc. 2Health News:How to Afford Health Care in Hard Times 2
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... Fitzgerald Inaugural Healthcare Conference taking place in ... at Le Parker Meridien Hotel. ... overview of the Company,s business during his live presentation ...
(Date:7/1/2015)... , July 1, 2015 Eli Lilly and Company ... the second quarter of 2015 on Thursday, July 23, 2015. ... with the investment community and media to further detail the ... at 9 a.m. EDT. Investors, media and the general public ... a link that will be posted on Lilly,s website at ...
(Date:7/1/2015)... -- Precyse, a leader in health information management (HIM) ... of its long term growth plan, the company has ... firm Pamplona Capital Management (Pamplona).  Precyse,s board and their ... NewSpring Capital, have approved this corporate transaction. ... facilities and systems across the United States ...
Breaking Medicine Technology:ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 3
... technology - Until now, if you wanted ... some of your patients while continuing to ... of patients, you had to keep a ... that has changed with Lifecard 12 - ...
... This direct fluorescent assays ... immunofluorescence technique to provide clear, ... 15 minutes. Chlamydia antigens ... antibody to the C. trachomatis ...
Inquire...
... Brachytherapy loaders allow for efficient, easy ... Connectors to your customized plans at ... Bard loaders is the flexibility to ... flexibility of the patented SourceLink™ Connector ...
Medicine Products: